Adage Capital Partners
ODTX

Adage Capital Partners’s Odyssey Therapeutics ODTX Stock Holding History

Adage Capital Partners’s Portfolio ODTX Stock Details ODTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Buy
+725,000
New +$12.7M 0.02% 634

Other funds holding ODTX

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $2.4B AUM 7.07% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Adage Capital Partners's ODTX Position: Q2 2026 in Review

Adage Capital Partners opened a new position in Odyssey Therapeutics (ODTX) in Q2 2026: 725,000 shares worth $13.6M. The stake represents 0.02% of the portfolio and ranks #634 among its holdings.

50 funds tracked by Wall St. Rank hold ODTX as of Q2 2026.

  • Adage Capital Partners held 725,000 shares of Odyssey Therapeutics worth $13.6M as of Q2 2026.
  • Odyssey Therapeutics was a new Adage Capital Partners position in Q2 2026.
  • Odyssey Therapeutics made up 0.02% of Adage Capital Partners's portfolio in Q2 2026, its #634 holding.
  • 50 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.